TP53 and colonic neoplasm: In addition, some studies have shown that increasing the expression of miR-203 and miR-22 in colon cancer cells with a mutation in TP53 can cause induction of apoptosis, inhibition of proliferation, decrease in survival and also increasing sensitivity to chemotherapy [90, 91] (Fig. 3C).